Biorepositories Asia Session Spotlight: Understand and Overcome Global Ethical Concerns to Obtain Approval from Ethics Committee

Leading up to Biorepositories Asia, we'll be highlighting a session from the upcoming conference. It will take place April 11-13, 2011, in San Francisco, California. For more information, download the brochure.

Featured Session: Understand and Overcome Global Ethical Concerns to Obtain Approval from Ethics Committee
Panelists: Rajeev Shrivastava, PhD, Senior Manager, Clinical Research, ELI LILLY AND COMPANY, INDIA

Amelia Wall Warner, PharmD, RPh, Head, Clinical Pharmacogenomics and Clinical Specimen Management Director, Experimental Medicine, MERCK RESEARCH LABORATORIES

Anita Nelsen, Manager, Genetics Sample Acquisition & R&D Human Sample BioRepository, GLAXOSMITHKLINE

Ethical issues and data privacy considerations can be a problematic barrier to global sample collection in Asia. Join this interactive discussion as industry leaders from multiple perspectives share open dialogue on some of the toughest issues surrounding sample management. Legal, regulatory, policy and ethical factors are addressed to help the industry manage patient privacy, while simultaneously pursuing the future potential of biospecimen research.

Discussion addresses how to:
• Manage variation with global ethics committees
• Understand protected health information and data confi dentiality laws and regulations
• Address concerns around collection for unspecific use
• Effectively communicate with global investigators and sites participating in clinical trials

Share this article with your social network, just click below to share now!

Share |